Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01204957 | Brown Seaweed as a Breast Cancer Preventive | completed | Phase 1 / Phase 2 | 33 | University of South CarolinaOTHER | 1 | Apr 6, 2015 | clinicaltrials |
| NCT00452673 | Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer | completed | Phase 1 | 52 | Bristol-Myers SquibbINDUSTRY | 3 | Mar 24, 2015 | clinicaltrials |
| Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer |
| completed |
| Phase 1 / Phase 2 |
| 31 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Mar 17, 2015 |
| clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT02015676 | A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 69 | Hoffmann-La RocheINDUSTRY | 1 | Mar 12, 2015 | clinicaltrials |
| NCT00704158 | Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 42 | CuraGen CorporationINDUSTRY | 1 | Feb 19, 2015 | clinicaltrials |
| NCT00106145 | A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014) | completed | Phase 1 | 103 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jan 30, 2015 | clinicaltrials |
| NCT01386580 | An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. | completed | Phase 1 / Phase 2 | 84 | BBB-Therapeutics B.V.INDUSTRY | 4 | Jan 22, 2015 | clinicaltrials |
| NCT01220570 | The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050) | completed | Phase 1 | 63 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jan 21, 2015 | clinicaltrials |
| NCT01895491 | Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer(VM206RY) | completed | Phase 1 | 9 | Reyon Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00100750 | Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Jan 13, 2015 | clinicaltrials |
| NCT00911898 | A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers(Monotherapy) | completed | Phase 1 | 20 | Merrimack PharmaceuticalsINDUSTRY | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01858116 | PET Study of Breast Cancer Patients Using [68Ga]ABY-025 | completed | Phase 1 / Phase 2 | 16 | Biomedical Radiation SciencesOTHER | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01095913 | Fluorescent Dyes for Lymph Node Mapping | completed | Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01097460 | MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer | completed | Phase 1 | 16 | Merrimack PharmaceuticalsINDUSTRY | 1 | Jan 7, 2015 | clinicaltrials |
| NCT00807781 | Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer | completed | Phase 1 | 15 | Washington University School of MedicineOTHER | 1 | Jan 5, 2015 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00825734 | Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 83 | SCRI Development Innovations, LLCOTHER | 1 | Dec 22, 2014 | clinicaltrials |
| NCT00968656 | Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1(FISO PET/CT) | completed | Phase 1 | 31 | Washington University School of MedicineOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01259505 | Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer | completed | Phase 1 | 10 | Tokyo Medical UniversityOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01238952 | Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer | completed | Phase 1 | 4 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT01245205 | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2014 | clinicaltrials |
| NCT01077453 | Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer | completed | Phase 1 | 112 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2014 | clinicaltrials |
| NCT01672684 | Phase I: At-Home Support for Rural Women Using Group Video Calling | completed | Phase 1 | 34 | Stanford UniversityOTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT01993576 | ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.(EC2075) | completed | Phase 1 / Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT00924352 | Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 56 | Accelerated Community Oncology Research NetworkOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT00393497 | A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment | completed | Phase 1 | 11 | Indiana UniversityOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00107211 | Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast | completed | Phase 1 | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00516243 | Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Sep 12, 2014 | clinicaltrials |
| NCT00003107 | Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors | completed | Phase 1 | — | Indiana UniversityOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT00027534 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 14 | Michael Morse, MDOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00405678 | Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy. | completed | Phase 1 / Phase 2 | 23 | Duke UniversityOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT01003158 | Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. | completed | Phase 1 | 17 | AstraZenecaINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01423123 | Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer | completed | Phase 1 | 21 | NSABP Foundation IncNETWORK | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00544804 | Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 1 | 41 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01256567 | A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer | completed | Phase 1 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00258349 | Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer | completed | Phase 1 / Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2014 | clinicaltrials |
| NCT00217399 | Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00470847 | Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer | completed | Phase 1 | 35 | Nancy Lin, MDOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01335152 | Online Stress Management and Coping Skills Training for Women With Breast Cancer | completed | Phase 1 / Phase 2 | 100 | Talaria, IncINDUSTRY | 1 | May 7, 2014 | clinicaltrials |
| NCT00364754 | Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer | completed | Phase 1 | 28 | YM BioSciencesINDUSTRY | 3 | Apr 21, 2014 | clinicaltrials |
| NCT00645333 | Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 4, 2014 | clinicaltrials |
| NCT00724386 | Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer | completed | Phase 1 | 26 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00348699 | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00068614 | HER-2 Protein Vaccine in Treating Women With Breast Cancer | completed | Phase 1 | — | Case Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00513058 | Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 33 | UNICANCEROTHER | 1 | Jan 14, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Apr 6, 2015source: clinicaltrials